… (IFN-γ) inhibits hepatitis B virus (HBV) replication noncytopathically in the livers of transgenic
mice. … mice replicate HBV in the liver at slightly higher levels than the respective controls, …

… the result of the control of viral replication by the host immune system.33, 34, 35 However,
cellular pathways and viral targets involved in this “control” of viral replication by the immune …

… We used human hepatoma HepAD38 cells, in which HBV production is under the control
of a tetracycline-regulated promotor, to investigate changes induced in the host …

… Control of viral replication is a major therapeutic goal to reduce morbidity and mortality from
chronic hepatitis B virus (… mechanism, and methylation of viral DNA leads to downregulation …

… duck hepatitis B virus, can be grown in tissue culture (34). … woodchuck hepatitis virus and
that of duck hepatitis B virus are … , 22) proteins under the control of HBV or cellular liver-specific …

… Similarly, transfection of lipofectamine alone had no effect on viral replication. Neither
siRNA nor the control compounds caused any cytotoxic or cytostastic effect, as was observed …

… EC90 values (90% effective concentration: drug concentration which induces a 90% decrease
in the levels of HBV DNA replication intermediates in treated versus untreated control cells…

… transmission and extrahepatic manifestations of hepatitis B. Another situation in which
treatment would be indicated is for the rapid control of viral replication in patients with severe HBV …

… Those observations imply that HBV replication might normally be controlled in cells by
the activation of tyrosine kinase-mediated signaling pathways and possibly by the PI3K-Akt …

… response, has the potential to control viral replication during natural HBV infection. In addition,
the data suggest that therapeutic activation of NKT cells may represent a new strategy for …